Literature DB >> 23197

Antinuclear antibodies in patients receiving non-practolol beta-blockers.

J D Wilson, J Y Bullock, D C Sutherland, C Main, K P O'Brien.   

Abstract

Antinuclear antibodies (ANA) were found in 54 (7.0%) out of 767 treated hypertensive patients compared with 59 (2.4%) out of 2470 healthy controls. Inclusion of a non-practolol beta-blocker in the treatment regimen did not significantly affect the incidence of ANA. ANA was found in significantly more patients being treated with methyldopa (13.0%) than patients receiving other hypotensive agents (3.8%). Non-practolol beta-blockers in combination with methyldopa did not increase the incidence of ANA further.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 23197      PMCID： PMC1602504          DOI： 10.1136/bmj.1.6104.14

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  3 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

3.  Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa.

Authors:  A Breckenridge; C T Dollery; S M Worlledge; E J Holborow; G D Johnson
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321
  3 in total
  11 in total

1.  Hippocampal Neural Circuits Respond to Optogenetic Pacing of Theta Frequencies by Generating Accelerated Oscillation Frequencies.

Authors:  Ipshita Zutshi; Mark P Brandon; Maylin L Fu; Macayla L Donegan; Jill K Leutgeb; Stefan Leutgeb
Journal:  Curr Biol       Date:  2018-04-05       Impact factor: 10.834

2.  Antinuclear factor in patients on prazosin.

Authors:  J D Wilson; R J Booth; J Y Bullock
Journal:  Br Med J       Date:  1979-02-24

3.  Hypotensive agents, beta-blockers, and drug-induced lupus.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-08

4.  Antinuclear antibodies in patients on acebutolol.

Authors:  R J Booth; J Y Bullock; J D Wilson
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

5.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 6.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

7.  A long-term study of labetalol in general practice.

Authors:  J Kane; I Gregg; M D Stephens
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

8.  Labetalol, a cross-over double blind controlled trial.

Authors:  G L Sanders; P A Routledge; J G Rao; G M Gales; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 9.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546

10.  A comparative study of methyldopa and labetalol in the treatment of hypertension.

Authors:  G L Sanders; D M Davies; G M Gales; J G Rao; M D Rawlins; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.